Home NDC 62756-148 Rivastigmine Tartrate
Product NDC 62756-148
11-digit product format 627560148
Labeler code 62756
Product ID 62756-148_a905f5ce-ae1b-4511-acd3-62883a3e3546
Type HUMAN PRESCRIPTION DRUG
Nonproprietary name Rivastigmine Tartrate
Dosage form CAPSULE
Route ORAL
Labeler Sun Pharmaceutical Industries, Inc.
Application ANDA077131
Marketing category ANDA
Marketing start 2010-07-01
Substance RIVASTIGMINE TARTRATE
Active strength 6 mg/1
Pharmacologic classes Cholinesterase Inhibitor [EPC], Cholinesterase Inhibitors [MoA]
NDC exclude flag No
Listing certified through 2026-12-31
Current FDA listing Yes Source provenance: Browse the complete Orange Book source catalog · source snapshot 1 .
Orange Book products# Current product rows page 1 of 1 · 4 matching rows.
Application-product, Trade name, Ingredient table Application-product Trade name Ingredient Strength Dosage form / route TE codes RLD / RS Approval date A077131-001 RIVASTIGMINE TARTRATE RIVASTIGMINE TARTRATE EQ 1.5MG BASE CAPSULE / ORAL 2007-10-22 A077131-002 RIVASTIGMINE TARTRATE RIVASTIGMINE TARTRATE EQ 3MG BASE CAPSULE / ORAL 2007-10-22 A077131-003 RIVASTIGMINE TARTRATE RIVASTIGMINE TARTRATE EQ 4.5MG BASE CAPSULE / ORAL 2007-10-22 A077131-004 RIVASTIGMINE TARTRATE RIVASTIGMINE TARTRATE EQ 6MG BASE CAPSULE / ORAL 2007-10-22
Observed Orange Book product history# Observed FDA ZIP history: Each table is queried independently by exact application/product key from successfully parsed Orange Book snapshots. Capture times identify archived source observations; absence or a change between snapshots is not inferred. FDA publication files that were not recoverable as structured ZIP data are not represented as states.
Product history page 1 of 5 · 164 observed states.
Captured, Edition, Application-product table Captured Edition Application-product Trade name Strength Dosage form / route Product TE source text RLD / RS Approval date Source SHA-256 2026-02-19 14:30 UTC 2026-02 A077131-001 RIVASTIGMINE TARTRATE EQ 1.5MG BASE CAPSULE / ORAL 2007-10-22 011fe1cb6892…2026-02-19 14:30 UTC 2026-02 A077131-002 RIVASTIGMINE TARTRATE EQ 3MG BASE CAPSULE / ORAL 2007-10-22 011fe1cb6892…2026-02-19 14:30 UTC 2026-02 A077131-003 RIVASTIGMINE TARTRATE EQ 4.5MG BASE CAPSULE / ORAL 2007-10-22 011fe1cb6892…2026-02-19 14:30 UTC 2026-02 A077131-004 RIVASTIGMINE TARTRATE EQ 6MG BASE CAPSULE / ORAL 2007-10-22 011fe1cb6892…2025-12-14 10:44 UTC · 2 captures of this ZIP 2025-12 A077131-001 RIVASTIGMINE TARTRATE EQ 1.5MG BASE CAPSULE / ORAL 2007-10-22 31067a03dcf5…2025-12-14 10:44 UTC · 2 captures of this ZIP 2025-12 A077131-002 RIVASTIGMINE TARTRATE EQ 3MG BASE CAPSULE / ORAL 2007-10-22 31067a03dcf5…2025-12-14 10:44 UTC · 2 captures of this ZIP 2025-12 A077131-003 RIVASTIGMINE TARTRATE EQ 4.5MG BASE CAPSULE / ORAL 2007-10-22 31067a03dcf5…2025-12-14 10:44 UTC · 2 captures of this ZIP 2025-12 A077131-004 RIVASTIGMINE TARTRATE EQ 6MG BASE CAPSULE / ORAL 2007-10-22 31067a03dcf5…2025-08-23 18:47 UTC 2025-08 A077131-001 RIVASTIGMINE TARTRATE EQ 1.5MG BASE CAPSULE / ORAL 2007-10-22 6a471c1ec25d…2025-08-23 18:47 UTC 2025-08 A077131-002 RIVASTIGMINE TARTRATE EQ 3MG BASE CAPSULE / ORAL 2007-10-22 6a471c1ec25d…2025-08-23 18:47 UTC 2025-08 A077131-003 RIVASTIGMINE TARTRATE EQ 4.5MG BASE CAPSULE / ORAL 2007-10-22 6a471c1ec25d…2025-08-23 18:47 UTC 2025-08 A077131-004 RIVASTIGMINE TARTRATE EQ 6MG BASE CAPSULE / ORAL 2007-10-22 6a471c1ec25d…2025-03-22 03:13 UTC · 3 captures of this ZIP 2025-03 A077131-001 RIVASTIGMINE TARTRATE EQ 1.5MG BASE CAPSULE / ORAL 2007-10-22 fd3edfee7708…2025-03-22 03:13 UTC · 3 captures of this ZIP 2025-03 A077131-002 RIVASTIGMINE TARTRATE EQ 3MG BASE CAPSULE / ORAL 2007-10-22 fd3edfee7708…2025-03-22 03:13 UTC · 3 captures of this ZIP 2025-03 A077131-003 RIVASTIGMINE TARTRATE EQ 4.5MG BASE CAPSULE / ORAL 2007-10-22 fd3edfee7708…2025-03-22 03:13 UTC · 3 captures of this ZIP 2025-03 A077131-004 RIVASTIGMINE TARTRATE EQ 6MG BASE CAPSULE / ORAL 2007-10-22 fd3edfee7708…2025-02-26 10:13 UTC · 3 captures of this ZIP 2025-02 A077131-001 RIVASTIGMINE TARTRATE EQ 1.5MG BASE CAPSULE / ORAL 2007-10-22 b8a1b40f171c…2025-02-26 10:13 UTC · 3 captures of this ZIP 2025-02 A077131-002 RIVASTIGMINE TARTRATE EQ 3MG BASE CAPSULE / ORAL 2007-10-22 b8a1b40f171c…2025-02-26 10:13 UTC · 3 captures of this ZIP 2025-02 A077131-003 RIVASTIGMINE TARTRATE EQ 4.5MG BASE CAPSULE / ORAL 2007-10-22 b8a1b40f171c…2025-02-26 10:13 UTC · 3 captures of this ZIP 2025-02 A077131-004 RIVASTIGMINE TARTRATE EQ 6MG BASE CAPSULE / ORAL 2007-10-22 b8a1b40f171c…2025-01-19 17:59 UTC · 7 captures of this ZIP 2025-01 A077131-001 RIVASTIGMINE TARTRATE EQ 1.5MG BASE CAPSULE / ORAL 2007-10-22 03ed91905a0d…2025-01-19 17:59 UTC · 7 captures of this ZIP 2025-01 A077131-002 RIVASTIGMINE TARTRATE EQ 3MG BASE CAPSULE / ORAL 2007-10-22 03ed91905a0d…2025-01-19 17:59 UTC · 7 captures of this ZIP 2025-01 A077131-003 RIVASTIGMINE TARTRATE EQ 4.5MG BASE CAPSULE / ORAL 2007-10-22 03ed91905a0d…2025-01-19 17:59 UTC · 7 captures of this ZIP 2025-01 A077131-004 RIVASTIGMINE TARTRATE EQ 6MG BASE CAPSULE / ORAL 2007-10-22 03ed91905a0d…2024-12-13 21:23 UTC · 2 captures of this ZIP 2024-12 A077131-001 RIVASTIGMINE TARTRATE EQ 1.5MG BASE CAPSULE / ORAL 2007-10-22 2680178bc6a6…2024-12-13 21:23 UTC · 2 captures of this ZIP 2024-12 A077131-002 RIVASTIGMINE TARTRATE EQ 3MG BASE CAPSULE / ORAL 2007-10-22 2680178bc6a6…2024-12-13 21:23 UTC · 2 captures of this ZIP 2024-12 A077131-003 RIVASTIGMINE TARTRATE EQ 4.5MG BASE CAPSULE / ORAL 2007-10-22 2680178bc6a6…2024-12-13 21:23 UTC · 2 captures of this ZIP 2024-12 A077131-004 RIVASTIGMINE TARTRATE EQ 6MG BASE CAPSULE / ORAL 2007-10-22 2680178bc6a6…2024-09-14 05:58 UTC · 2 captures of this ZIP 2024-09 A077131-001 RIVASTIGMINE TARTRATE EQ 1.5MG BASE CAPSULE / ORAL AB 2007-10-22 5bbf6a4d5a75…2024-09-14 05:58 UTC · 2 captures of this ZIP 2024-09 A077131-002 RIVASTIGMINE TARTRATE EQ 3MG BASE CAPSULE / ORAL AB 2007-10-22 5bbf6a4d5a75…2024-09-14 05:58 UTC · 2 captures of this ZIP 2024-09 A077131-003 RIVASTIGMINE TARTRATE EQ 4.5MG BASE CAPSULE / ORAL AB 2007-10-22 5bbf6a4d5a75…2024-09-14 05:58 UTC · 2 captures of this ZIP 2024-09 A077131-004 RIVASTIGMINE TARTRATE EQ 6MG BASE CAPSULE / ORAL AB 2007-10-22 5bbf6a4d5a75…2024-11-08 22:44 UTC · 3 captures of this ZIP 2024-11 A077131-001 RIVASTIGMINE TARTRATE EQ 1.5MG BASE CAPSULE / ORAL 2007-10-22 d8e5a09893c0…2024-11-08 22:44 UTC · 3 captures of this ZIP 2024-11 A077131-002 RIVASTIGMINE TARTRATE EQ 3MG BASE CAPSULE / ORAL 2007-10-22 d8e5a09893c0…2024-11-08 22:44 UTC · 3 captures of this ZIP 2024-11 A077131-003 RIVASTIGMINE TARTRATE EQ 4.5MG BASE CAPSULE / ORAL 2007-10-22 d8e5a09893c0…2024-11-08 22:44 UTC · 3 captures of this ZIP 2024-11 A077131-004 RIVASTIGMINE TARTRATE EQ 6MG BASE CAPSULE / ORAL 2007-10-22 d8e5a09893c0…2024-10-29 15:01 UTC 2024-10 A077131-001 RIVASTIGMINE TARTRATE EQ 1.5MG BASE CAPSULE / ORAL AB 2007-10-22 d06236e962d9…2024-10-29 15:01 UTC 2024-10 A077131-002 RIVASTIGMINE TARTRATE EQ 3MG BASE CAPSULE / ORAL AB 2007-10-22 d06236e962d9…2024-10-29 15:01 UTC 2024-10 A077131-003 RIVASTIGMINE TARTRATE EQ 4.5MG BASE CAPSULE / ORAL AB 2007-10-22 d06236e962d9…2024-10-29 15:01 UTC 2024-10 A077131-004 RIVASTIGMINE TARTRATE EQ 6MG BASE CAPSULE / ORAL AB 2007-10-22 d06236e962d9…
Observed Orange Book normalized TE history# Normalized TE history page 1 of 4 · 128 observed states.
Additional Listing Data#
Finished product Yes
Brand name base Rivastigmine Tartrate
Listing expiration 2026-12-31 Active Ingredients# Ingredient, Strength table Ingredient Strength RIVASTIGMINE TARTRATE 6 mg/1
Harmonized UNII identifiers# UNII identifiers page 1 of 1 · 1 matching rows.
Identifier, FDA.report destination table Identifier FDA.report destination 9IY2357JPE Internal UNII lookup
Harmonized RxCUI identifiers# RxCUI identifiers page 1 of 1 · 4 matching rows.
Identifier, FDA.report destination table Identifier FDA.report destination 312835 Internal RxNorm lookup 312836 Internal RxNorm lookup 314214 Internal RxNorm lookup 314215 Internal RxNorm lookup
Harmonized SPL set identifiers# SPL set identifiers page 1 of 1 · 1 matching rows.
DailyMed Product Concepts# DailyMed Package Descriptions# Package NDC, Product, Description table Package NDC Product Description Form Quantity Strength SPL version 62756-148-13 Rivastigmine Tartrate 500 in 1 BOTTLE CAPSULE 500 8 62756-148-61 Rivastigmine Tartrate 1 in 1 BLISTER PACK CAPSULE 1 8 62756-148-61 Rivastigmine Tartrate 100 in 1 BOX, UNIT-DOSE CAPSULE 100 8 62756-148-86 Rivastigmine Tartrate 60 in 1 BOTTLE CAPSULE 60 8
DailyMed Socrata Ingredients# Ingredient, Type, UNII table Ingredient Type UNII DailyMed label SPL version Uploaded RIVASTIGMINE TARTRATE ACTIVE INGREDIENT 9IY2357JPE RIVASTIGMINE TARTRATE CAPSULE [SUN PHARMACEUTICAL INDUSTRIES LIMITED ] 5 RIVASTIGMINE ACTIVE MOIETY PKI06M3IW0 RIVASTIGMINE TARTRATE CAPSULE [SUN PHARMACEUTICAL INDUSTRIES LIMITED ] 5 ALCOHOL INACTIVE INGREDIENT 3K9958V90M RIVASTIGMINE TARTRATE CAPSULE [SUN PHARMACEUTICAL INDUSTRIES LIMITED ] 5 AMMONIA INACTIVE INGREDIENT 5138Q19F1X RIVASTIGMINE TARTRATE CAPSULE [SUN PHARMACEUTICAL INDUSTRIES LIMITED ] 5 BUTYL ALCOHOL INACTIVE INGREDIENT 8PJ61P6TS3 RIVASTIGMINE TARTRATE CAPSULE [SUN PHARMACEUTICAL INDUSTRIES LIMITED ] 5 CELLULOSE, MICROCRYSTALLINE INACTIVE INGREDIENT OP1R32D61U RIVASTIGMINE TARTRATE CAPSULE [SUN PHARMACEUTICAL INDUSTRIES LIMITED ] 5 D&C RED NO. 28 INACTIVE INGREDIENT 767IP0Y5NH RIVASTIGMINE TARTRATE CAPSULE [SUN PHARMACEUTICAL INDUSTRIES LIMITED ] 5 D&C YELLOW NO. 10 INACTIVE INGREDIENT 35SW5USQ3G RIVASTIGMINE TARTRATE CAPSULE [SUN PHARMACEUTICAL INDUSTRIES LIMITED ] 5 FD&C RED NO. 40 INACTIVE INGREDIENT WZB9127XOA RIVASTIGMINE TARTRATE CAPSULE [SUN PHARMACEUTICAL INDUSTRIES LIMITED ] 5 FD&C YELLOW NO. 6 INACTIVE INGREDIENT H77VEI93A8 RIVASTIGMINE TARTRATE CAPSULE [SUN PHARMACEUTICAL INDUSTRIES LIMITED ] 5 FERRIC OXIDE RED INACTIVE INGREDIENT 1K09F3G675 RIVASTIGMINE TARTRATE CAPSULE [SUN PHARMACEUTICAL INDUSTRIES LIMITED ] 5 FERRIC OXIDE YELLOW INACTIVE INGREDIENT EX438O2MRT RIVASTIGMINE TARTRATE CAPSULE [SUN PHARMACEUTICAL INDUSTRIES LIMITED ] 5 FERROSOFERRIC OXIDE INACTIVE INGREDIENT XM0M87F357 RIVASTIGMINE TARTRATE CAPSULE [SUN PHARMACEUTICAL INDUSTRIES LIMITED ] 5 GELATIN INACTIVE INGREDIENT 2G86QN327L RIVASTIGMINE TARTRATE CAPSULE [SUN PHARMACEUTICAL INDUSTRIES LIMITED ] 5 MAGNESIUM STEARATE INACTIVE INGREDIENT 70097M6I30 RIVASTIGMINE TARTRATE CAPSULE [SUN PHARMACEUTICAL INDUSTRIES LIMITED ] 5 POTASSIUM HYDROXIDE INACTIVE INGREDIENT WZH3C48M4T RIVASTIGMINE TARTRATE CAPSULE [SUN PHARMACEUTICAL INDUSTRIES LIMITED ] 5 PROPYLENE GLYCOL INACTIVE INGREDIENT 6DC9Q167V3 RIVASTIGMINE TARTRATE CAPSULE [SUN PHARMACEUTICAL INDUSTRIES LIMITED ] 5 SHELLAC INACTIVE INGREDIENT 46N107B71O RIVASTIGMINE TARTRATE CAPSULE [SUN PHARMACEUTICAL INDUSTRIES LIMITED ] 5 SILICON DIOXIDE INACTIVE INGREDIENT ETJ7Z6XBU4 RIVASTIGMINE TARTRATE CAPSULE [SUN PHARMACEUTICAL INDUSTRIES LIMITED ] 5 TITANIUM DIOXIDE INACTIVE INGREDIENT 15FIX9V2JP RIVASTIGMINE TARTRATE CAPSULE [SUN PHARMACEUTICAL INDUSTRIES LIMITED ] 5 RIVASTIGMINE TARTRATE ACTIVE INGREDIENT 9IY2357JPE RIVASTIGMINE TARTRATE CAPSULE [PHYSICIANS TOTAL CARE, INC.] 1 RIVASTIGMINE ACTIVE MOIETY PKI06M3IW0 RIVASTIGMINE TARTRATE CAPSULE [PHYSICIANS TOTAL CARE, INC.] 1 CELLULOSE, MICROCRYSTALLINE INACTIVE INGREDIENT OP1R32D61U RIVASTIGMINE TARTRATE CAPSULE [PHYSICIANS TOTAL CARE, INC.] 1 FD&C RED NO. 40 INACTIVE INGREDIENT WZB9127XOA RIVASTIGMINE TARTRATE CAPSULE [PHYSICIANS TOTAL CARE, INC.] 1 FD&C YELLOW NO. 6 INACTIVE INGREDIENT H77VEI93A8 RIVASTIGMINE TARTRATE CAPSULE [PHYSICIANS TOTAL CARE, INC.] 1 FERRIC OXIDE RED INACTIVE INGREDIENT 1K09F3G675 RIVASTIGMINE TARTRATE CAPSULE [PHYSICIANS TOTAL CARE, INC.] 1 FERRIC OXIDE YELLOW INACTIVE INGREDIENT EX438O2MRT RIVASTIGMINE TARTRATE CAPSULE [PHYSICIANS TOTAL CARE, INC.] 1 GELATIN INACTIVE INGREDIENT 2G86QN327L RIVASTIGMINE TARTRATE CAPSULE [PHYSICIANS TOTAL CARE, INC.] 1 MAGNESIUM STEARATE INACTIVE INGREDIENT 70097M6I30 RIVASTIGMINE TARTRATE CAPSULE [PHYSICIANS TOTAL CARE, INC.] 1 SILICON DIOXIDE INACTIVE INGREDIENT ETJ7Z6XBU4 RIVASTIGMINE TARTRATE CAPSULE [PHYSICIANS TOTAL CARE, INC.] 1 TITANIUM DIOXIDE INACTIVE INGREDIENT 15FIX9V2JP RIVASTIGMINE TARTRATE CAPSULE [PHYSICIANS TOTAL CARE, INC.] 1
DailyMed Dashboard NDC Coverage# NDC, Dashboard title, SPL version table NDC Dashboard title SPL version Validation Dashboard ZIP 62756-148 RIVASTIGMINE TARTRATE CAPSULE [SUN PHARMACEUTICAL INDUSTRIES, INC.] 8 Current NDC, Legacy NDC, 4 package rows 20190205_bac9ca81-db70-41aa-82af-6c5bb8496846.zip
openFDA label cross-check# OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.
Matched openFDA labels page 1 of 1 · 1 matching rows.
DailyMed RxNorm Mappings# Packages# Package NDC, 11-digit format, Description table Package NDC 11-digit format Description Units Marketing start Marketing end Sample Exclude flag Status 62756-148-13 62756014813 500 CAPSULE in 1 BOTTLE (62756-148-13) 500 capsule 2010-07-01 0000-00-00 No No Current 62756-148-61 62756014861 100 BLISTER PACK in 1 BOX, UNIT-DOSE (62756-148-61) / 1 CAPSULE in 1 BLISTER PACK 100 blister pack 2010-07-01 0000-00-00 No No Current 62756-148-86 62756014886 60 CAPSULE in 1 BOTTLE (62756-148-86) 60 capsule 2010-07-01 0000-00-00 No No Current